1993
DOI: 10.1097/00004872-199303000-00013
|View full text |Cite
|
Sign up to set email alerts
|

Hypertension in Diabetes Study (HDS): II. Increased risk of cardiovascular complications in hypertensive type 2 diabetic patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2001
2001
2024
2024

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 158 publications
(7 citation statements)
references
References 0 publications
0
7
0
Order By: Relevance
“…Demographics, lifestyle variables, dietary habits, and personal medical and family history were obtained using a predesigned questionnaire based on factors associated with dysglycemia found in other populations. [9][10][11][12][13][14][15][18][19][20][21][22] Participants were instructed to fast overnight for 8 to 14 hours, and fasting blood sample was collected to estimate fasting plasma glucose (FPG) and glycated hemoglobin (HbA1c). Another sample was collected 1 hour after ingestion of 50-g glucose solution (CASCO NERL Diagnostics, East Providence, RI, USA) for estimating plasma glucose (1-hour oral glucose tolerance test; 1 h-OGTT).…”
Section: Study Design and Data Collectionmentioning
confidence: 99%
“…Demographics, lifestyle variables, dietary habits, and personal medical and family history were obtained using a predesigned questionnaire based on factors associated with dysglycemia found in other populations. [9][10][11][12][13][14][15][18][19][20][21][22] Participants were instructed to fast overnight for 8 to 14 hours, and fasting blood sample was collected to estimate fasting plasma glucose (FPG) and glycated hemoglobin (HbA1c). Another sample was collected 1 hour after ingestion of 50-g glucose solution (CASCO NERL Diagnostics, East Providence, RI, USA) for estimating plasma glucose (1-hour oral glucose tolerance test; 1 h-OGTT).…”
Section: Study Design and Data Collectionmentioning
confidence: 99%
“…In this context, a leading risk factor for CVD mortality is high blood pressure (BP), which accounts for > 40% of CVD-related deaths worldwide (Danaei et al, 2014). In individuals with type 2 diabetes mellitus (T2DM), elevated BP further increases the risk of CVD (Turner et al, 1993), whilst T2DM itself imposes a risk of coronary heart disease mortality equivalent to that of a prior myocardial infarction (Juutilainen et al, 2005). Moreover, a recent study confirmed a time dependent and additive effect of BP and increasing blood glucose levels on the development of T2DM complications (Stratton et al, 2006).…”
Section: Introductionmentioning
confidence: 99%
“…It has also been shown that hypertension in diabetic patients is observed more often than in nondiabetic individuals ( ). These associations carry a significant increase in mortality and morbidity due to atherosclerosis and microvascular diabetic complications such as nephropathy and retinopathy ( ). It is recognized that the management of hypertension especially in the diabetic patient is complicated by multiple factors related to the metabolic state, that is, glucose and lipid levels and insulin resistance.…”
Section: Introductionmentioning
confidence: 99%